300026.SZ
300026.SZ
CNE100000GF1
CHASE SUN PHARM.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2024 2023 Change %
Total Revenue 5.782.766.929 6.108.854.649
5.3%
Cost of Revenue 2.731.900.618 2.803.386.935
2.5%
Gross Profit 3.050.866.311 3.305.467.715
7.7%
2.789.632.332 2.667.037.332
4.6%
Operating Income 261.233.979 638.430.383
59.1%
Pretax Income 53.984.535 606.823.073
91.1%
Net Income Common Stockholders 21.467.323 506.631.426
95.8%
-- --
--
-- --
--
ende